Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Frank Milton Balis, M.D.

Frank Milton Balis, M.D.

faculty photo
Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
The Children's Hospital of Philadelphia
3501 Civic Center Blvd., Room CTRB4024
Philadelphia, PA 19104
Office: 267-426-5414
Fax: 267-425-0113
Education:
B.S. (Zoology)
University of North Carolina, 1971.
M.D. (Medicine)
Vanderbilt University, 1975.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Description of Clinical Expertise

Solid tumors in children, renal tumors in children, clinical pharmacology of anticancer drugs

Description of Research Expertise

Clinical pharmacology of anticancer drugs

Selected Publications

Barakat LP, Schwartz LA, Reilly A, Deatrick JA, Balis FM: A qualitative study of phase III cancer clinical trial enrollment decision-making: Perspectives from adolescents, young adults, caregivers, and providers. J Adolesc Young Adult Oncol 3: 3, 2014.

Nella AA, Lodish MB, Fox E, Balis FM, Quezado MM, Whitcomb PO, Derdak J, Kebebew E, Widemann BC, Stratakis CA: Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient. J Clin Endocrinol Metab 2014.

Widemann BC, Dombi E, Gillespie A, Wolters P, Belasco J, Goldman S, Korf B, Solomon J, Martin S, Salzer W, Fox E, Patronas N, Kieran M, Perentesis J, Reddy A, Wright J, Kim A, Steinberg S, Balis FM: Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Neuro-oncol 16: 707, 2014.

Adamson PC, Balis FM, Bagatell R, Blaney SM: General principles of chemotherapy. Principles and Practice of Pediatric Oncology 6th Ed. Pizzo PA, Adamson PC and Poplack DG (eds.). Lippincott Williams & Wilkins, 2014.

Fox E, Mosse YP, Meany HM, Gurney J, Khanna G, Jackson HA, Krivoshik A, Gordon G, Shusterman S, Park JP, Cohn S, Adamson PC, McGrady P, London W, Maris JM, Balis FM: Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: A Children’s Oncology Group Phase 2 Trial (ANBL0621). Pediatr Blood Cancer 61: 990, 2014.

Widemann BC, Babovic-Vuksanovic D, Dombi E, Wolters PL, Goldman S, MartinS, Goodwin A, Goodspeed W, Kieran MW, Cohen B, Blaney SM, King A, Solomon J, Patronas N, Balis FM, Fox E, Steinberg SM, Packer RJ: Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Pediatr Blood Cancer 2014.

Desai A, Fox E, Smith M, Lim A, Maris JM, Balis FM: Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastoma. Cancer Chemother Pharmacol 2014.

Desai A, Fox E, Smith M, Lim A, Maris JM, Balis FM: Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastoma. Cancer Chemother Pharmacol 2014.

Fox Elizabeth, Widemann Brigitte C, Chuk Meredith K, Marcus Leigh, Aikin Alberta, Whitcomb Patricia O, Merino Maria J, Lodish Maya, Dombi Eva, Steinberg Seth M, Wells Samuel A, Balis Frank M: Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma. Clin Cancer Res 19(15): 4239-48, Aug 2013.

Mossé Yael P, Lim Megan S, Voss Stephan D, Wilner Keith, Ruffner Katherine, Laliberte Julie, Rolland Delphine, Balis Frank M, Maris John M, Weigel Brenda J, Ingle Ashish M, Ahern Charlotte, Adamson Peter C, Blaney Susan M: Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. Lancet Oncol 14(6): 472-80, May 2013.

back to top
Last updated: 10/02/2014
The Trustees of the University of Pennsylvania